/Medtronic%20Plc%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Headquartered in Galway, Ireland, Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies. With a market cap of approximately $115 billion, the company derives revenue from four core segments: Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio, and Diabetes.
MDT stock has surged 10.6% over the past year, trailing behind the S&P 500 Index ($SPX), which surged by 21.1% during the same period. However, year-to-date, MDT stock has advanced by 11.9%, outpacing the S&P 500’s 7.9% gain.